Providence Capital Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.65M | Buy |
30,129
+840
| +3% | +$102K | 0.67% | 58 |
|
|
2025
Q1 | $3.27M | Buy |
29,289
+369
| +1% | +$41.1K | 0.68% | 60 |
|
|
2024
Q4 | $2.81M | Buy |
28,920
+7
| +0% | +$681 | 0.57% | 69 |
|
|
2024
Q3 | $3.33M | Sell |
28,913
-6,620
| -19% | -$761K | 0.66% | 64 |
|
|
2024
Q2 | $3.78M | Buy |
35,533
+416
| +1% | +$44.3K | 0.82% | 50 |
|
|
2024
Q1 | $3.4M | Buy |
35,117
+813
| +2% | +$78.6K | 0.74% | 57 |
|
|
2023
Q4 | $3.46M | Sell |
34,304
-1,103
| -3% | -$111K | 0.83% | 52 |
|
|
2023
Q3 | $3.61M | Buy |
35,407
+193
| +0.5% | +$19.7K | 0.94% | 51 |
|
|
2023
Q2 | $3.55M | Buy |
35,214
+518
| +1% | +$52.3K | 0.9% | 52 |
|
|
2023
Q1 | $3.19M | Buy |
34,696
+588
| +2% | +$54.1K | 0.84% | 53 |
|
|
2022
Q4 | $3.09M | Sell |
34,108
-2
| -0% | -$181 | 0.84% | 55 |
|
|
2022
Q3 | $2.59M | Buy |
34,110
+698
| +2% | +$53.1K | 0.78% | 59 |
|
|
2022
Q2 | $2.82M | Buy |
33,412
+10,595
| +46% | +$895K | 0.82% | 57 |
|
|
2022
Q1 | $1.99M | Buy |
22,817
+1,835
| +9% | +$160K | 0.49% | 82 |
|
|
2021
Q4 | $1.84M | Buy |
20,982
+833
| +4% | +$72.9K | 0.51% | 74 |
|
|
2021
Q3 | $1.65M | Buy |
20,149
+1,857
| +10% | +$152K | 0.51% | 74 |
|
|
2021
Q2 | $1.67M | Buy |
18,292
+1,095
| +6% | +$99.9K | 0.54% | 67 |
|
|
2021
Q1 | $1.47M | Buy |
17,197
+372
| +2% | +$31.8K | 0.53% | 69 |
|
|
2020
Q4 | $1.59M | Buy |
16,825
+1,715
| +11% | +$162K | 0.65% | 57 |
|
|
2020
Q3 | $1.31M | Buy |
15,110
+488
| +3% | +$42.4K | 0.69% | 54 |
|
|
2020
Q2 | $1.28M | Sell |
14,622
-122
| -0.8% | -$10.7K | 0.72% | 53 |
|
|
2020
Q1 | $1.22M | Buy |
+14,744
| New | +$1.22M | 0.73% | 56 |
|
|
2018
Q1 | – | Sell |
-50
| Closed | -$4K | – | 286 |
|
|
2017
Q4 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 279 |
|